BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19857688)

  • 1. Prediction of graft loss and death in patients with primary sclerosing cholangitis.
    Kornasiewicz O; Lewandowski Z; Dudek K; Stankiewicz R; Nyckowski P; Krawczyk M
    Transplant Proc; 2009 Oct; 41(8):3110-3. PubMed ID: 19857688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver transplantation for primary sclerosing cholangitis in the Nordic countries: outcome after acceptance to the waiting list.
    Brandsaeter B; Broomé U; Isoniemi H; Friman S; Hansen B; Schrumpf E; Oksanen A; Ericzon BG; Höckerstedt K; Mäkisalo H; Olsson R; Olausson M; Kirkegaard P; Bjøro K
    Liver Transpl; 2003 Sep; 9(9):961-9. PubMed ID: 12942458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting clinical and economic outcomes after liver transplantation using the Mayo primary sclerosing cholangitis model and Child-Pugh score. National Institutes of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database Group.
    Talwalkar JA; Seaberg E; Kim WR; Wiesner RH
    Liver Transpl; 2000 Nov; 6(6):753-8. PubMed ID: 11084063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinically recurrent primary sclerosing cholangitis following liver transplantation: a time course.
    Campsen J; Zimmerman MA; Trotter JF; Wachs M; Bak T; Steinberg T; Kam I
    Liver Transpl; 2008 Feb; 14(2):181-5. PubMed ID: 18236392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis.
    Graziadei IW; Wiesner RH; Marotta PJ; Porayko MK; Hay JE; Charlton MR; Poterucha JJ; Rosen CB; Gores GJ; LaRusso NF; Krom RA
    Hepatology; 1999 Nov; 30(5):1121-7. PubMed ID: 10534330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
    Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF
    Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrence of primary sclerosing cholangitis in patients after liver transplantation.
    Ołdakowska-Jedynak U; Nowak M; Mucha K; Foroncewicz B; Nyckowski P; Zieniewicz K; Ziarkiewicz-Wróblewska B; Patkowski W; Górnicka B; Paczkowska A; Michałowicz B; Pilecki T; Pawlak J; Krawczyk M; Paczek L
    Transplant Proc; 2006; 38(1):240-3. PubMed ID: 16504713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biliary malignancies in primary sclerosing cholangitis: timing for liver transplantation.
    Nashan B; Schlitt HJ; Tusch G; Oldhafer KJ; Ringe B; Wagner S; Pichlmayr R
    Hepatology; 1996 May; 23(5):1105-11. PubMed ID: 8621141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver transplantation for sclerosing cholangitis.
    Narumi S; Roberts JP; Emond JC; Lake J; Ascher NL
    Hepatology; 1995 Aug; 22(2):451-7. PubMed ID: 7635412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts.
    Alabraba E; Nightingale P; Gunson B; Hubscher S; Olliff S; Mirza D; Neuberger J
    Liver Transpl; 2009 Mar; 15(3):330-40. PubMed ID: 19243003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list.
    Ferraz-Neto BH; Hidalgo R; Thomé T; Melo VA; Lobue A; Zurstrassen MP; Moraes JM; Meira-Filho SP; Rezende MB; Fonseca LE; Pandullo FL; Soeiro FS; Afonso RC
    Transplant Proc; 2007 Oct; 39(8):2511-3. PubMed ID: 17954160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretransplant prediction of prognosis after liver transplantation in primary sclerosing cholangitis using a Cox regression model.
    Neuberger J; Gunson B; Komolmit P; Davies MH; Christensen E
    Hepatology; 1999 May; 29(5):1375-9. PubMed ID: 10216118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis.
    Kim WR; Poterucha JJ; Wiesner RH; LaRusso NF; Lindor KD; Petz J; Therneau TM; Malinchoc M; Dickson ER
    Hepatology; 1999 Jun; 29(6):1643-8. PubMed ID: 10347102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical outcome in patients with primary sclerosing cholangitis undergoing ileal pouch-anal anastomosis: a case-control study.
    Gorgun E; Remzi FH; Manilich E; Preen M; Shen B; Fazio VW
    Surgery; 2005 Oct; 138(4):631-7; discussion 637-9. PubMed ID: 16269291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Native liver xanthogranulomatous cholangiopathy in primary sclerosing cholangitis: impact on posttransplant outcome.
    Keaveny AP; Gordon FD; Goldar-Najafi A; Lewis WD; Pomfret EA; Pomposelli JJ; Jenkins RL; Khettry U
    Liver Transpl; 2004 Jan; 10(1):115-22. PubMed ID: 14755787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Midterm cost-effectiveness of the liver transplantation program of England and Wales for three disease groups.
    Longworth L; Young T; Buxton MJ; Ratcliffe J; Neuberger J; Burroughs A; Bryan S;
    Liver Transpl; 2003 Dec; 9(12):1295-307. PubMed ID: 14625830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation.
    Kugelmas M; Spiegelman P; Osgood MJ; Young DA; Trotter JF; Steinberg T; Wachs ME; Bak T; Kam I; Everson GT
    Liver Transpl; 2003 Jul; 9(7):727-32. PubMed ID: 12827560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary sclerosing cholangitis: role of extrahepatic biliary resection.
    Pawlik TM; Olbrecht VA; Pitt HA; Gleisner AL; Choti MA; Schulick RD; Cameron JL
    J Am Coll Surg; 2008 May; 206(5):822-30; discussion 830-2. PubMed ID: 18471705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cause-specific hazard rate analysis of prognostic factors among 877 adults who received primary orthotopic liver transplantation.
    Gaynor JJ; Moon JI; Kato T; Nishida S; Selvaggi G; Levi DM; Island ER; Pyrsopoulos N; Weppler D; Ganz S; Ruiz P; Tzakis AG
    Transplantation; 2007 Jul; 84(2):155-65. PubMed ID: 17667806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical course of inflammatory bowel disease in patients transplanted for primary sclerosing cholangitis].
    Villamil A; De Paula JA; Galdame O; Piccioni H; Ciardullo M; De Santibañes E; Gadano A
    Acta Gastroenterol Latinoam; 2008 Dec; 38(4):252-9. PubMed ID: 19157380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.